Highlights
- •
Iron elevation causes inward mitochondrial Ca2+ overflow via an Fe2+-MCU interaction (mitochondrial calcium uniporter = MCU).- •
In PD neurons, this Fe2+-Ca2+ signal causes Ca2+ elevation at the OMM (outer mitochondrial membrane)- •
OMM Ca2+ levels are sensed by Miro1 (a Ca2+-binding protein.)- •
Miro1-based drug screens in PD cells identify Ca2+-channel blockers
This is a free paper and I think this is also very important to ATH: The paper demonstrates how the increased iron will do on the mitochondrial level. And even more about how iron chelation will help: "Chelating iron, reducing Ca2+ entry into the cell, or blocking Miro1’s binding to Ca2+ is each neuroprotective". IMO, this was seen in the primate study. Miro1 can be used as a measure of treatment efficacy.
Here is the abstract, but better to read the free paper.A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson's disease
AffiliationsAffiliations
- 1Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 2Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA; Graduate Program of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 3Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA; Institut du Cerveau - Paris Brain Institute - ICM, 75013 Paris, France.
- 4Vroom Inc., Houston, TX 77042, USA.
- 5Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
- 6Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 7Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 8Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: [email protected].
DOI: 10.1016/j.celrep.2023.113544Free article
- PMID: 38060381
Abstract
Dysregulated iron or Ca2+ homeostasis has been reported in Parkinson's disease (PD) models. Here, we discover a connection between these two metals at the mitochondria. Elevation of iron levels causes inward mitochondrial Ca2+ overflow, through an interaction of Fe2+ with mitochondrial calcium uniporter (MCU). In PD neurons, iron accumulation-triggered Ca2+ influx across the mitochondrial surface leads to spatially confined Ca2+ elevation at the outer mitochondrial membrane, which is subsequently sensed by Miro1, a Ca2+-binding protein. A Miro1 blood test distinguishes PD patients from controls and responds to drug treatment. Miro1-based drug screens in PD cells discover Food and Drug Administration-approved T-type Ca2+-channel blockers. Human genetic analysis reveals enrichment of rare variants in T-type Ca2+-channel subtypes associated with PD status. Our results identify a molecular mechanism in PD pathophysiology and drug targets and candidates coupled with a convenient stratification method.
- Forums
- ASX - By Stock
- ATH
- Stanford scientists: iron-calcium in mitochondrion as target in PD treatment
Stanford scientists: iron-calcium in mitochondrion as target in PD treatment
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.6¢ | 0.5¢ | $3.342K | 666.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 32719984 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 15288198 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 32719984 | 0.005 |
33 | 56248682 | 0.004 |
42 | 43611649 | 0.003 |
13 | 27343014 | 0.002 |
12 | 93270101 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 15288198 | 22 |
0.007 | 18686670 | 20 |
0.008 | 14885875 | 17 |
0.009 | 6171000 | 7 |
0.010 | 2370000 | 3 |
Last trade - 14.04pm 29/05/2024 (20 minute delay) ? |
|
|||||
Last
0.6¢ |
  |
Change
0.000 ( 10.0 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.6¢ | 0.5¢ | 140816 | ||
Last updated 11.48am 29/05/2024 ? |
Featured News
ATH (ASX) Chart |